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Background: Hippocampal volume (HV) decline is an important marker of psychosis and has been associated
with hypothalamus–pituitary–adrenal (HPA) axis dysregulation in various disorders. Given recent ﬁndings of
sex differences in HPA axis function in psychosis, the current study investigated differences in HV in male and
female ﬁrst episode psychosis (FEP) patients and controls and the interaction of HV with the cortisol awakening
response (CAR) and symptoms.
Methods: Fifty-eight patients with a diagnosis of FEP (39 men, 19 women) and 27 healthy community controls
(15 men, 12women) underwent structural magnetic resonance imaging (MRI) on a 1.5 T scanner. Hippocampal
volumewas determined using previously established segmentation protocols. Saliva samples for cortisol assess-
ment were collected at 0, 30 and 60 min after awakening. Psychotic symptoms were assessed with the Scale for
Assessment of Positive Symptoms (SAPS), the Scale for Assessment of Negative Symptoms (SANS) and theGlobal
Assessment of Functioning (GAF) scale.
Results:Male patients had signiﬁcantly smaller left and right HVs compared to male controls, which appeared to
be secondary to global brain volume differences. However, evenwhen controlling for overall brain size, male pa-
tients showed smaller HV compared to female patients. The CAR was signiﬁcantly lower in male patients com-
pared to male controls and female patients. Only in male patients, smaller left HV was signiﬁcantly associated
with a blunted CAR, and smaller HV bilaterally was related to positive psychotic symptoms and lower levels of
functioning.
Conclusions:We propose that reduced hippocampal volume and an attenuated cortisol awakening response are
relatedmarkers of increased stress vulnerability inmale psychosis patients and that both contribute to the unfa-
vorable clinical picture in men.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY–NC–ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Reduced hippocampal volume (HV) is a common ﬁnding in psychot-
ic disorders (Adriano et al., 2012; Nelson et al., 1998; Pantelis et al.,
2003; Steen et al., 2006; Velakoulis et al., 2006). It is apparent early in
the course of psychosis, and further progression of structural abnormal-
ities is observed as the illness evolves (Pantelis et al., 2003; Steen et al.,
2006). Hippocampal volume reduction has been implicated in various
aspects of thepathophysiology of psychosis including symptomseverity
(Bodnar et al., 2010;Watson et al., 2012), cognitive function and insight
(Buchy et al., 2010; Harrison, 2004).vention Program for Psychosis,
ilion, 6875 Boulevard LaSalle,
6131; ext.: 3381; fax: 001 514
sner).
. This is an open access article underSmallerHVhas been associatedwith abnormal regulation of thehypo-
thalamus–pituitary–adrenal (HPA) axis in various neuropsychiatric con-
ditions (Sapolsky, 2000). A dysregulation of HPA axis function is
increasingly observed in psychosis, characterized by diurnal hyperactivity
and a blunted cortisol response to awakening and to acute stress (Borges
et al., 2013; Mondelli et al., 2010b; Pruessner et al., 2008; Pruessner et al.,
2013; Ritsner et al., 2007; Ryan et al., 2004; vanVenrooij et al., 2012). Still,
very few researchers have investigated the relationship betweenHPAaxis
function and HV in psychosis. A recent study reported an association be-
tween higher diurnal cortisol levels and smaller HV in ﬁrst episode psy-
chosis (FEP) patients (Mondelli et al., 2010b), but a previous study had
not found such a relationship (Gunduz-Bruce et al., 2007).
Research in patients with hippocampal damage suggests that re-
duced hippocampal integrity speciﬁcally compromises the cortisol
awakening response (CAR), with diurnal cortisol secretion remaining
intact (Buchanan et al., 2004; Wolf et al., 2005). Our research group
has recently demonstrated a blunted CAR particularly in male FEPthe CC BY–NC–ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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this ﬁnding might be related to hippocampal and other gray matter ab-
normalities. Indeed, male psychosis patients show signiﬁcantly greater
structural brain abnormalities compared to female patients, such as
larger ventricles (Nopoulos et al., 1997), smaller frontal lobes (Bora
et al., 2012), smaller medial temporal lobe volumes (Gur et al., 2000)
and reduced hippocampal volume (Adriano et al., 2012; Bogerts et al.,
1990a; Bora et al., 2012; Bryant et al., 1999; Exner et al., 2008; Irle
et al., 2011).
The present study was designed to assess sex differences in hippo-
campal volume and their relationship with the cortisol awakening re-
sponse and symptoms of psychosis. We hypothesized that reduced
hippocampal volume will be associated with an attenuated cortisol
awakening response and that both these measures will be related to
symptom severity particularly in male patients.
2. Material and methods
2.1. Subjects
Fifty-eight patients with a ﬁrst episode of psychosis (39 men, 19
women) were recruited from the Prevention and Early Intervention
Program for Psychosis (PEPP) (Malla et al., 2003) at the Douglas Mental
HealthUniversity Institute inMontreal. All patientswerewithin theﬁrst
2 years of treatment and follow-up for a ﬁrst episode of psychosis, had
less than 30 days of exposure to antipsychotic medication prior to ad-
mission, and were recruited to the present study when they were
deemed clinically stable to participate. Since patients usually stabilize
within 3 months of admission, most were recruited within the ﬁrst
6 months, assuring limited exposure to antipsychotic medications.
Overlap of patients with our previous report (Pruessner et al., 2013)
was 62%. Twenty-seven healthy community controls (15 men, 12
women) were recruited through advertisements in local free newspa-
pers. Control subjectswere screenedwith a telephone interview follow-
ed by a diagnostic interview with the Structured Clinical Interview for
DSM IV, non-patient edition (SCID-NP) (First et al., 2002) to rule out a
diagnosis of a mental disorder in the subjects themselves or in their
ﬁrst degree relatives, as well as use of psychotropic or other medication
that could affect HPA axis functioning. All study procedures were ap-
proved by the McGill Institutional Review Board, and participants pro-
vided written informed consent prior to participation in the study.
2.2. Hippocampal volume assessment
All participants underwent structural high-resolution (isotropic
1 mm) MRI on a Siemens 1.5 T scanner. Hippocampal volume was de-
termined using an appearance model-based automatic segmentation
method with patch based local reﬁnement (Hu et al., 2011) and was
quality-controlled by a validated rater employing our manual segmen-
tation protocol for this structure (Pruessner et al., 2000). As a measure
of total brain volume differences, the individual scaling factor used to
transform native into normalized brain volumes based on the MNI
152 template (Mazziotta et al., 1995) was employed.
2.3. The cortisol awakening response
All participants received oral and written instructions for saliva
sampling with the Salivette© sampling device (Sarstedt, Quebec
City, Canada) at 0, 30 and 60 min after awakening. Participants were
instructed not to eat or drink before and during the sampling time and
to refrain from brushing their teeth. Samples were stored in a −20°C
freezer until analysis. Cortisol was analyzed using a time-resolved immu-
noassay with ﬂuorescence detection (Dressendorfer et al., 1992). Intra-
and inter- assay coefﬁcients of variation were smaller than 10% and 12%,
respectively.2.4. Symptom assessment
Psychotic symptoms were assessed with the Scale for Assessment of
Positive Symptoms (SAPS) (Andreasen, 1984) and the Scale for Assess-
ment of Negative Symptoms (SANS) (Andreasen, 1983). Attention
items were excluded for the SANS. Functioning was assessed with the
Global Assessment of Functioning (GAF) scale (Luborsky, 1962), and
depression was assessed with the Calgary Depression Scale (CDS)
(Addington et al., 1990).2.5. Statistical analyses
Differences in all demographic and biological measureswere assessed
ﬁrst between the patient and control group as a whole, then in the male
and female subgroups, and ﬁnally between male and female patients.
Clinical and treatment related variables were compared in male and fe-
male patients. T-tests were employed for normally distributed data,
Mann–Whitney U-tests for skewed data and Chi-Square tests for binary
data. For biological variables, univariate ANOVAswere employed to assess
group (patients, controls) differences stratiﬁed by sex in total brain and
left and right hippocampal volume. Repeated measures (0, 30, 60 min)
ANOVAs were used to determine group and sex differences in the CAR.
These analyses were repeated with ANCOVAs controlling for potential
confounders. Both native HV and HV adjusted for total brain size were
employed as dependent variables to demonstrate actual volume differ-
ences and the impact of global brain volume. In order to assess sex differ-
ences in the patient and control groups, we conducted ANCOVAs with
hippocampal volume corrected for total brain size as dependent variable,
controlling for medication dose and other relevant confounders. Chlor-
promazine equivalents (CPZEs) of individual medication dosages were
calculated according to Bezchlibnik-Butler and Jeffries (2006). Paired
t-testswere used to assess hemisphere differences in HV. In order to ob-
tain a single value for correlational analyses including the CAR, we cal-
culated the area under the curve with respect to ground (Pruessner
et al., 2003). Spearman correlations were utilized to assess associations
between HV, scaling factor, CAR, and symptoms. Demographic and
treatment related variables were included as covariates in partial corre-
lations where applicable.3. Results
3.1. Demographic and clinical characteristics
Patients were younger than controls at trend level, reported higher
rates of cannabis use and cigarette smoking and were more likely to
be single. Table 1 provides details on demographic variables in male
and female patients and controls. No signiﬁcant differences between
male and female patients were observed in the ratio of non-affective
versus affective psychosis, duration of untreated psychosis, duration of
untreated illness, positive and negative symptom severity, global func-
tioning and treatment with antipsychotic medication. Table 2 provides
details on these patient characteristics for men and women. Higher
medication dose was signiﬁcantly related to impairment in global func-
tioning and more severe negative symptoms inmale (rho=−.49; p=
.006 and rho = .59; p = .005; respectively) but not female patients
(rho= .49; p= .087 and p N .75; respectively). In male patients, higher
medication dose was also related to smaller right hippocampal volume
(rho=−.38; p= .037). No such relationshipwithmedication dosewas
observed for left HV (p N .12), total brain volume (p N .66) or the CAR
(p N .75). No association between biological variables and medication
dose was observed in female patients (all p N .55). Age, cannabis use,
cigarette smoking and relationship status were included as covariates
in subsequent analyses comparing patients and controls where applica-
ble. Medication dose was included as covariate when comparing male
and female patients.
Table 1
Group and sex differences in socio-demographic variables and smoking.
Total group Patients (N = 58) Controls (N = 27) Statistic p-Value
Age, N (SD) 23.87 (3.71) 22.26 (3.61) t = 1.88 .064
Sex, male, N (%) 39 (67.2) 15 (55.6) χ2 = 1.09 .297
Education N high school, N (%) 28 (48.3) 18 (66.7) χ2 = 2.51 .113
Ethnicity, white, N (%) 45 (77.6) 21 (77.8) χ2 = 0.00 .984
Relationship status, single, N (%) 54 (93.1) 19 (70.4) χ2 = 7.85 .005
Cannabis use past 3 months, N (%) 25 (43.1) 5 (18.5) χ2 = 4.88 .027
Tobacco smoking, N5 cigarettes/day, N (%) 32 (55.2) 5 (18.5) χ2 = 10.1 .002
Patients only Men (N = 39) Women (N = 19) Statistic p-Value
Age, N (SD) 23.79 (3.69) 24.04 (3.83) t = –.24 .812
Education N high school, N (%) 17 (43.6) 11 (57.9) χ2 = 1.05 .306
Ethnicity, white, N (%) 30 (76.9) 15 (78.9) χ2 = .030 .862
Relationship status, single, N (%) 37 (94.9) 17 (89.5) χ2 = .580 .446
Cannabis use past 3 months, N (%) 18 (46.2) 7 (36.8) χ2 = .452 .502
Tobacco smoking, N5 cigarettes/day, N (%) 23 (59.0) 9 (47.4) χ2 = .696 .404
Men only Patients (N = 39) Controls (N = 15) Statistic p-Value
Age, N (SD) 23.79 (3.69) 21.60 (3.62) t = 1.96 .055
Education N high school, N (%) 17 (43.6) 10 (66.7) χ2 = 2.31 .129
Ethnicity, white, N (%) 30 (76.9) 11 (73.3) χ2 = 0.08 .782
Relationship status, single, N (%) 37 (94.9) 13 (86.7) χ2 = 1.06 .302
Cannabis use past 3 months, N (%) 18 (46.2) 3 (20.0) χ2 = 3.12 .077
Tobacco smoking, N5 cigarettes/day, N (%) 23 (59.0) 3 (20.0) χ2 = 6.59 .010
Women only Patients (N = 19) Controls (N = 12) Statistic p-Value
Age, N (SD) 24.04 (3.83) 23.08 (3.58) t = 0.69 .494
Education N high school, N (%) 11 (57.9) 8 (66.7) χ2 = 0.24 .625
Ethnicity, white, N (%) 15 (78.9) 10 (83.3) χ2 = 0.09 .763
Relationship status, single, N (%) 17 (89.5) 6 (50.0) χ2 = 5.98 .014
Cannabis use past 3 months, N (%) 7 (36.8) 2 (16.7) χ2 = 1.45 .228
Tobacco smoking, N5 cigarettes/day, N (%) 9 (47.4) 2 (16.7) χ2 = 3.03 .082
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Univariate ANOVAs revealed that left and right hippocampal volume
were signiﬁcantly smaller in patients compared to controls.When strat-
ifying the groups by sex, the differences between patients and controls
were only signiﬁcant in men (F(1) = 8.88; p = .004 and F(1) = 8.26;
p = .006, respectively; Fig.1). Global brain volume was also smaller in
male patients compared to male controls. Those group differences
were still signiﬁcant when ANCOVAs were conducted which includedTable 2
Patient characteristics: Diagnoses and treatment.
Male
(N = 39)
Non-affective psychosisa, N (%) 29 (74.4)
Duration of untreated illness (DUI), weeks (median) 211.1
Duration of untreated psychosis (DUP), weeks (median) 17.14
Symptom ratings:
Positive symptoms (SAPS), mean (SE) 11.48 (2.25)
Negative symptoms (SANS), mean (SE) 22.69 (2.09)
Global assessment of functioning (GAF), mean (SE) 48.69 (3.11)
Depression (CDS), mean (SE) 3.72 (0.82)
Time treated with antipsychotics, weeks (median) 16.71
Dosage of antipsychotic medication (CPZE)b, mean (SD) 180.8 (159.6)
Antipsychotic medication prescribed, N (%)
Olanzapine 12 (30.8)
Risperidone (oral) 10 (25.6)
Risperidone (injectable)b 7 (18.0)
Quetiapine 4 (10.3)
Aripiprazoleb 1 (2.6)
Paliperidoneb 1 (2.6)
Clozapine 1 (2.6)
Ziprasidone 1 (2.6)
No antipsychotic medication 2 (5.1)
a According to the SCID, as apposed to affective psychosis.
b Chlorpromazine equivalent doses; could not be calculated for patients treated with palipeage, cannabis use, cigarette smoking and relationship status as covari-
ates (see Table 3 for details). When repeating these analyses with hip-
pocampal volumes corrected for total brain size, differences between
patients and controls were not signiﬁcant anymore (all p N .40), sug-
gesting that the observed volume differences in the hippocampus
were secondary to global brain volume differences.
In order to compare the difference in hippocampal volume in male
and female patients, we conducted ANCOVAs within the patient group
with sex (male, female) as independent variable and hippocampalFemale
(N = 19)
Statistic p-Value
13 (68.4) χ2 = 0.23 .635
282.0 Z = –1.64 .101
15.71 Z = –0.52 .603
7.94 (2.08) T(56) = 1.00 .322
18.56 (2.23) T(56) = 1.34 .185
56.32 (4.01) T(56) = –1.45 .153
4.94 (1.61) T(55) = –0.75 .455
17.26 Z = –0.42 .673
141.5 (112.1) T(41) = 0.80 .427
7 (35.9)
4 (21.1.)
1 (5.3)
1 (5.3)
3 (15.8)
2 (10.5)
0 (0.0)
0 (0.0)
1 (5.3)
ridone, aripiprazole and long-acting injectable risperidone.
2700
2900
3100
3300
3500
3700
left right left right
elamefelam
H
ip
po
ca
m
pa
l v
ol
um
e 
(m
m
3)
FEP Controls- 8.2% **
- 7.7% **
-2.7%   n.s.
-3.7%  n.s.  
**    p < .006
n.s.   p > .228
Fig. 1. Hippocampal volume in male and female FEP patients and controls.
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trolling for medication dose, age, cannabis use, smoking and relation-
ship status. Male patients showed signiﬁcantly smaller left and right
hippocampal volumes compared to female patients (F(1) = 19.14;
p b .001 and F(1) = 16.84; p b .001, respectively). In controls, relative
left and right volume of the hippocampus was also smaller inmen com-
pared to women, but the difference was only signiﬁcant for the right
and not for the left hippocampus (F(1) = 4.41; p = .048 and p = .34,
respectively). Paired sample t-tests revealed smaller left compared to
right HV in both patients and controls (t(57) = –5.96; p b .001 and
t(26) = –4.02; p b .001), and both men and women. The strongest dif-
ference between left and right HVs was observed in male patients
(t(38) = –5.74; p b .001).
The CAR was signiﬁcantly smaller in patients compared to controls
(F(1)= 8.03; p= .006), but further analysis revealed that this difference
was only signiﬁcant in male but not female participants (F(1) = 5.65;
p= .021 and F(1)= 1.62; p= .214, respectively; see Table 3 for details).
The CAR was signiﬁcantly smaller in men compared to women in both
patients and controls (F = 4.26; p = .044 and F = 4.96; p = .037,
respectively).Table 3
Hippocampal volume and cortisol awakening response in male and female patients and contro
Total group FEP (N = 58) Control
Left HV, mean (SD)a 3136.5 (323.1) 3305
Right HV, mean (SD)a 3259.6 (343.9) 3435
Scaling factor (SD)b 1.249 (0.130) 1.20
CAR AUCg, mean (SD)c 693.0 (398.4) 932
Time of awakening, mean (SD)d 8:51 a.m. (1:53) 8:23 a.m
Men FEP (N = 39) Control
Left HV, mean (SD)a 3214.7 (336.9) 3503
Right HV, mean (SD)a 3349.2 (351.5) 3629
Scaling factorb 1.194 (0.095) 1.10
CAR AUCg, mean (SD)c 620.1 (368.6) 861
Time of awakening, mean (SD)d 9:01 a.m. (2:01) 8:1
Women FEP (N = 19) Control
Left HV, mean (SD)a 2975.9 (224.8) 3059
Right HV, mean (SD)a 3075.7 (246.6) 3193
Scaling factorb 1.363 (0.119) 1.31
CAR AUCg, mean (SD)c 842.7 (425.1) 1021
Time of awakening, mean (SD)d 8:31 a.m. (1:36) 8:3
a Hippocampal volume, native space.
b Transformation factor from native into standard space, indicates total brain volume differe
c Cortisol awakening response (area under the curve with respect to ground).
d At the time of cortisol assessment.
e Controlling for age, cigarette smoking, cannabis use and relationship status.3.3. Associations between hippocampal volume and the CAR
In the total patient group, both left and right HVs (relative to total
brain size) were related to the CAR at trend level (rho = .24; p = .073
and rho = .25; p = .059; respectively). No such association was ob-
served in controls (pN .222).When separating the groups by sex,we ob-
served a signiﬁcant correlation between the CAR and left hippocampal
volume only in male patients (rho= .37; p= .021; see Fig. 2). This cor-
relation was still signiﬁcant when an outlier with cortisol levels more
than three standard deviations above the group mean was excluded
from the analysis (rho = .37; p = .024). The correlation between
right HV and the CAR in male patients was signiﬁcant at trend level
(p = .10). No signiﬁcant association between left or right HV and the
CAR was observed in female patients (both p N .50) and in male or fe-
male controls (all p N .13). When controlling for medication dose, can-
nabis use and cigarette smoking employing partial correlations in a
subgroup of patients for which CPZEmedication dose could be calculat-
ed (30 men, 13 women), the association between the CAR and left and
right HV in male patients was still signiﬁcant (r(24) = .39; p = .011
and r(24)= .40; p = .034; respectively). Again, no association was ob-
served in female patients (all p N .21) and in male or female controls,
controlling for cannabis use and smoking (all p N .50). No association
was observed between the CAR and total brain volume in either group
or sex (all p N .14).
3.4. Association between biological measures and symptoms
In the total patient group, smaller left and right HVs (adjusted
for total brain size) were associated with lower global functioning
(rho = .29; p = .026 and rho = .32; p = .016; respectively). Total
brain volume differences were not related to symptoms in the total
group (p N .22). When separated by sex, smaller left and right HVs in
male patients were signiﬁcantly associated with lower global function-
ing (both rho= .38; p= .017) andmore positive symptoms of psycho-
sis (rho=−.39; p= .014 and rho=−.37; p= .020; respectively). No
such associations with symptoms were observed in female patients (all
p N .18) and for total brain volume (p N .10). Hippocampal and total
brain volumes were not associated with negative symptoms and de-
pression in either sex (all p N .18). Hippocampal volume was also not
signiﬁcantly related to DUP or DUI (all p N .14). Controlling for cannabisls.
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Fig. 2. Spearman correlation between left hippocampal volume and the cortisol awaken-
ing response in male ﬁrst episode psychosis patients.
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lations conﬁrmed the association between left and right HVs and posi-
tive symptoms in men (r(36) = –40; p = .012 and r(36) = –36; p =
.029; respectively). However, when controlling for medication dose in
a subgroup of patients, the previously observed associations between
hippocampal volume and symptoms were not signiﬁcant anymore (all
p N .11). A more blunted CAR in patients was associated with a lower
level of global functioning at trend level (rho = .24; p = .069). The
CAR was not related to any other symptoms in the total patient group
or when separated by sex (all p N .12).4. Discussion
The present study investigated sex differences in hippocampal vol-
ume and their association with the cortisol awakening response and
symptoms in patients with a ﬁrst episode of psychosis. As hypothesized,
HV was signiﬁcantly reduced in male patients both in comparison to
male controls and to female patients. The observed HV differences be-
tween male patients and controls appeared to be secondary to whole
brain volume differences and to be superimposed on HV differences be-
tween men and women, rendering male psychosis patients particularly
vulnerable to HV loss. We furthermore observed a blunted CAR speciﬁ-
cally inmale patients and demonstrated an association between smaller
HV and the lower CAR again only inmale patients. Smaller left and right
HVs were related to impaired global functioning and more positive
symptoms inmale patients only. To the best of our knowledge, the pres-
ent study is the ﬁrst to demonstrate a sex-speciﬁc relationship of small-
er HVwith both a blunted CAR and higher symptom severity in patients
with a diagnosis of ﬁrst-episode psychosis.
Our results conﬁrm recent independentﬁndings of sex differences in
psychosis with regard to HV reduction (Adriano et al., 2012; Bogerts
et al., 1990b; Bora et al., 2012; Exner et al., 2008; Irle et al., 2011) and
HPA axis regulation (Pruessner et al., 2008; Pruessner et al., 2013).
The ﬁndings are also in line with several recent studies showing a rela-
tionship between reduced hippocampal volume and more severe posi-
tive symptoms (Bodnar et al., 2010; Brambilla et al., 2013; Ebdrup et al.,
2011; Kuhn et al., 2012; Watson et al., 2012). Sex differences in these
studies may have been masked by the consistently larger proportion
of male patients.
The observed correlation between reduced HV and a dysregulated
HPA axis resembles ﬁndings in various disorders such as depression
(O3rBrien et al., 1996), post-traumatic stress disorder (Yehuda, 2001),
Cushing3s syndrome (Starkman et al., 1992), aging (Lupien et al.,
1998) and, more recently, FEP (Mondelli et al., 2010b). This association
has been explained by the role of the hippocampus as amediator of neg-
ative feedback in situations of elevated glucocorticoid levels (Jacobsonand Sapolsky, 1991; Pruessner et al., 2010). Chronically elevated cortisol
levels have been shown to cause atrophy of dendrites in the hippocam-
pal CA3 region and suppression of neurogenesis of dentate gyrus
granule neurons (McEwen, 1999), which can result in overall volume
reduction of the structure and further dysregulation of the HPA axis.
On the other hand, hippocampal integrity can already be compromised
due to genetic and neurodevelopmental abnormalities and early life
adversity, constituting risk factors for the development of HPA dysregu-
lation in response to subsequent traumatic or other chronic stress situ-
ations (Buss et al., 2007; Gilbertson et al., 2002; Smith et al., 2003).
The observed relationship between HV reduction and HPA axis dys-
regulation and the association of both with functional and symptom
outcomes are in accordance with the neural-diathesis stress model of
schizophrenia (Walker and Diforio, 1997) and support the notion that
both biological factors together are implicated in the disease process
of psychosis. In fact, ourﬁndings suggest that the neural-diathesis stress
model might be particularly relevant for male patients. The here report-
ed sex differences in neurobiological variables could furthermore be re-
lated to other disadvantages in male compared to female patients such
as a higher rate of treated incidence of psychosis (Aleman et al., 2003;
Anderson et al., 2012), an earlier age of onset (Angermeyer and Kuhn,
1988), and a poorer treatment response (Angermeyer et al., 1990).
In accordance with previous studies, the left hippocampus was gen-
erally smaller than the right in both patients and healthy controls
(Adriano et al., 2012) and was particularly reduced in FEP patients
(Buehlmann et al., 2010; Malchow et al., 2013; Velakoulis et al., 2006).
Notably smaller left HV was related to a blunted CAR, which resembles
another recent study in FEP patients reporting smaller left hippocampal
volume in associationwith higher diurnal cortisol levels (Mondelli et al.,
2010b). Studies reporting smaller left HV in adults diagnosedwith PTSD
or dissociative identity disorder (Bremner et al., 1997; Stein et al., 1997)
and FEP patients (Hoy et al., 2012) who experienced childhood trauma,
suggest that stress related mechanisms are implicated in left HV loss.
Similarly, another recent study demonstrated an association of small
left HV with increased emotional and cortisol reactivity to stress in
schizophrenia patients and healthy siblings (Collip et al., 2011).
Compromised hippocampal integrity impairs episodic, relational
and spatial memory processes (Bohbot et al., 1998; Cohen et al., 1999;
Eichenbaum, 1999; Squire, 1992). Indeed, some research suggests that
male schizophrenia patients may be more vulnerable to cognitive deﬁ-
cits (Goldstein et al., 1998) and show reduced volume in brain regions
implicated in verbal memory circuitry (Abbs et al., 2011). It has been
suggested that theCARoccurs in response to “activation ofmemory rep-
resentations about the self and orientation in time and space upon
awakening” (Fries et al., 2009). Pathological changes to the hippocam-
pus might compromise these cognitive representations and the associ-
ated cortisol response, thus rendering male patients more vulnerable
to stress.
It has been suggested that sex and gender differences in schizophrenia
are a consequence of sex differences in brain development and a higher
susceptibility of male fetuses to environmental insults (Goldstein et al.,
2002; Seeman, 2008). A factor that not only is crucially involved in the
sexual differentiation of the brain but also affects a variety of other neuro-
nal and behavioral processes in development and adulthood is estrogen
(Abel et al., 2010; Hafner, 2003;McEwen, 2002; Seeman, 1997). Estrogen
receptors have been identiﬁed in many brain structures, importantly
those comprising the HPA axis, including the hippocampus (McEwen,
2002), and gonadal steroids have effects on the HPA response to stress
(Handa and Weiser, 2014; Kirschbaum et al., 1999). The putative neuro-
protective effect of estrogen in women and its absence in men has been
suggested as an explanation for the relatively greater hippocampal
volume decline over time in men (Hu et al., 2013; Lord et al., 2008;
Pruessner et al., 2001; Pruessner et al., 2010). Estrogen has furthermore
been shown to improve hippocampus dependent learning and memory
(McEwen, 2002). In psychosis, the ‘estrogen hypothesis’ is supported by
the lower prevalence rate and more favorable course of schizophrenia
200 M. Pruessner et al. / NeuroImage: Clinical 7 (2015) 195–202in women before menopause, higher rates of illness onset after meno-
pause, and variability of psychotic symptoms over the menstrual cycle
(Huber et al., 2004; Riecher-Rossler et al., 1994).
Another inﬂuential developmental factor is early life adversity,
which can have important consequences for HPA axis regulation
(Heim et al., 2008; Heim et al., 2009; Liu et al., 1997), hippocampal in-
tegrity (Buss et al., 2007; Driessen et al., 2000) and the development
of psychosis (Fisher et al., 2013; Matheson et al., 2013; van Winkel
et al., 2013; Varese et al., 2012) in adulthood. Some studies suggest
that men might be particularly vulnerable to the effects of early life ad-
versity on long-term mental health outcomes (Kivimaki et al., 2002;
Pruessner et al., 2013; Shevlin et al., 2007). In support of this notion,
we have recently reported an association between the blunted CAR in
male FEP patients and poor self-reported parental bonding (Pruessner
et al., 2013).
A limitation of the study is the cross sectional design,whichprevents
conclusive insights about cause and effect in the observed variables. Fur-
ther limitations are the small sample size in the control group and the
smaller number of female patients, which compromised the statistical
power to detect signiﬁcant associations in these subgroups. We have
not considered several potential confounders of cortisol levels such as
daylight exposure (Vreeburg et al., 2009), activity levels (Labsy et al.,
2013) and oral contraceptive use (Bouma et al., 2009). The observed
sex difference in HV might not be speciﬁc to psychosis, as it appears to
begin in young adulthood even in a healthy population (Pruessner
et al., 2001). It cannot be excluded that medication dose had an impact
on hippocampal volume, although it is likely that the higher medication
dose, seemingly explaining the relationship between hippocampal vol-
ume and symptoms, was a consequence of the relationship between
symptom severity and medication dose in male patients. It could be
considered another limitation that the CAR was the only measure of
HPA axis regulation in the current study given that changes in the CAR
do not necessarily correspond with diurnal measures of HPA function
(Mondelli et al., 2010a).
In conclusion, our ﬁndings demonstrate sex speciﬁc reductions in
hippocampal volume that are closely connected to HPA axis regulation
and symptoms. We propose that these ﬁndings are likely a consequence
of sex differences in neurodevelopment and a lack of the neuroprotective
effects of estrogen, renderingmenmore vulnerable to the effects of stress
andmore prone to developmental illness. Our results add to an increas-
ing number of ﬁndings showing a disadvantage for male patients with
psychosis. A better understanding of the associations between various
pathophysiological mechanisms involved in the expression of sex differ-
ences in psychosis is expected to explain some of the heterogeneity in ill-
ness phenotypes, to reconcile inconsistent ﬁndings, and to open up new
avenues for the development of effective interventions.
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